Importer of Controlled Substances; Notice of Registration; Hospira, 31986 [2014-12795]
Download as PDF
<![CDATA[
31986
Federal Register / Vol. 79, No. 106 / Tuesday, June 3, 2014 / Notices
Suite D, Windsor, Colorado 80550,
applied to be registered as a bulk
manufacturer of Carfentanil (9743), a
basis class of narcotic controlled
substance listed in schedule II.
The company plans to manufacture
the above listed controlled substance for
sale to veterinary pharmacies, zoos, and
other animal and wildlife applications.
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–12792 Filed 6–2–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[Docket No. DEA–392]
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before July 3, 2014. Such persons
may also file a written request for a
hearing on the application pursuant to
21 CFR 1301.43 on or before July 3,
2014.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been redelegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to sec. 7(g) of 28 CFR pt. 0,
subpt. R, App.
In accordance with 21 CFR
1301.34(a), this is notice that on March
5, 2014, Alltech Associates, Inc., 2051
Waukegan Road, Deerfield, Illinois
sroberts on DSK4SPTVN1PROD with NOTICES
Jkt 232001
I
I
II
II
II
II
II
II
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic class of controlled
substance listed.
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2014–12795 Filed 6–2–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application:
MALLINCKRODT, LLC
ACTION:
Notice of application.
BILLING CODE 4410–09–P
DATES:
17:35 Jun 02, 2014
I
[FR Doc. 2014–12793 Filed 6–2–14; 8:45 am]
Notice of application.
VerDate Mar<15>2010
Gamma
Hydroxybutyric
Acid
(2010).
Lysergic acid diethylamide (7315)
Heroin (9200) ...............................
Cocaine (9041) .............................
Codeine (9050) .............................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Methadone (9250) ........................
Morphine (9300) ...........................
Schedule
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
Importer of Controlled Substances
Application: Alltech Associates, Inc.
SUPPLEMENTARY INFORMATION:
Controlled substance
The company plans to import these
controlled substances for the
manufacture of reference standards.
Drug Enforcement Administration
ACTION:
60015, applied to be registered as an
importer of the following basic classes
of narcotic or non-narcotic controlled
substances:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before August 4, 2014.
DATES:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; Hospira
By Notice dated December 16, 2013,
and published in the Federal Register
on January 2, 2014, 79 FR 151, Hospira,
1776 North Centennial Drive,
McPherson, Kansas 67460–1247, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of
Remifentanil (9739), a basic class of
controlled substance listed in schedule
II.
The company plans to import
Remifentanil for use in dosage form
manufacturing.
No comments or objections have been
received. The DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Hospira to import the basic class of
controlled substance is consistent with
the public interest and in accordance
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA has investigated Hospira to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been redelegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to sec. 7(g) of 28 CFR pt. 0,
subpt. R, App.
In accordance with 21 CFR
1301.33(a), this is notice that on January
16, 2014, Mallinckrodt, LLC., 3600
North Second Street, St. Louis, Missouri
63147, applied to be registered as a bulk
manufacturer of the following basic
classes of narcotic or nonnarcotic
controlled substances:
SUPPLEMENTARY INFORMATION:
E:\FR\FM\03JNN1.SGM
03JNN1
]]>Agencies
[Federal Register Volume 79, Number 106 (Tuesday, June 3, 2014)]
[Notices]
[Page 31986]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-12795]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration;
Hospira
By Notice dated December 16, 2013, and published in the Federal
Register on January 2, 2014, 79 FR 151, Hospira, 1776 North Centennial
Drive, McPherson, Kansas 67460-1247, made application by renewal to the
Drug Enforcement Administration (DEA) to be registered as an importer
of Remifentanil (9739), a basic class of controlled substance listed in
schedule II.
The company plans to import Remifentanil for use in dosage form
manufacturing.
No comments or objections have been received. The DEA has
considered the factors in 21 U.S.C. 823(a) and 952(a) and determined
that the registration of Hospira to import the basic class of
controlled substance is consistent with the public interest and in
accordance with United States obligations under international treaties,
conventions, or protocols in effect on May 1, 1971. The DEA has
investigated Hospira to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above named company is granted
registration as an importer of the basic class of controlled substance
listed.
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2014-12795 Filed 6-2-14; 8:45 am]
BILLING CODE 4410-09-P
